China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294

Watchlist Manager
China Resources Boya Bio pharmaceutical Group Co Ltd Logo
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Watchlist
Price: 31.43 CNY -3.68% Market Closed
Market Cap: 15.8B CNY
Have any thoughts about
China Resources Boya Bio pharmaceutical Group Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
China Resources Boya Bio pharmaceutical Group Co Ltd

Wall Street analysts forecast China Resources Boya Bio pharmaceutical Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for China Resources Boya Bio pharmaceutical Group Co Ltd is 35.99 CNY with a low forecast of 34.13 CNY and a high forecast of 38.85 CNY.

Lowest
Price Target
34.13 CNY
9% Upside
Average
Price Target
35.99 CNY
15% Upside
Highest
Price Target
38.85 CNY
24% Upside
China Resources Boya Bio pharmaceutical Group Co Ltd Competitors:
Price Targets
688062
Mabwell Shanghai Bioscience Co Ltd
60% Upside
FHTX
Foghorn Therapeutics Inc.
111% Upside
688363
Bloomage Biotechnology Corp Ltd
0% Upside
BONEX
Bonesupport Holding AB
5% Upside
VITR
Vitrolife AB
23% Upside
OXB
Oxford BioMedica PLC
25% Upside
ORGO
Organogenesis Holdings Inc
18% Upside
NRIX
Nurix Therapeutics Inc
42% Upside

Revenue
Forecast

Revenue Estimate
China Resources Boya Bio pharmaceutical Group Co Ltd

For the last 8 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's revenue is 22%. The projected CAGR for the next 3 years is -3%.

22%
Past Growth
-3%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
China Resources Boya Bio pharmaceutical Group Co Ltd

For the last 8 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's operating income is 17%. The projected CAGR for the next 3 years is 13%.

17%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
China Resources Boya Bio pharmaceutical Group Co Ltd

For the last 8 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's net income is 6%. The projected CAGR for the next 3 years is 45%.

6%
Past Growth
45%
Estimated Growth
Estimates Accuracy
-23%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is China Resources Boya Bio pharmaceutical Group Co Ltd's stock price target?
Price Target
35.99 CNY

According to Wall Street analysts, the average 1-year price target for China Resources Boya Bio pharmaceutical Group Co Ltd is 35.99 CNY with a low forecast of 34.13 CNY and a high forecast of 38.85 CNY.

What is China Resources Boya Bio pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
-3%

For the last 8 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's revenue is 22%. The projected CAGR for the next 3 years is -3%.

What is China Resources Boya Bio pharmaceutical Group Co Ltd's Operating Income forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's operating income is 17%. The projected CAGR for the next 3 years is 13%.

What is China Resources Boya Bio pharmaceutical Group Co Ltd's Net Income forecast?
Projected CAGR
45%

For the last 8 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's net income is 6%. The projected CAGR for the next 3 years is 45%.

Back to Top